BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sattianayagam PT, Gillmore JD, Pinney JH, Gibbs SD, Wechalekar AD, Gilbertson JA, Rowczenio D, Hawkins PN, Lachmann HJ. Inflammatory bowel disease and systemic AA amyloidosis. Dig Dis Sci 2013;58:1689-97. [PMID: 23371008 DOI: 10.1007/s10620-012-2549-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 van Hoeve K, Hoffman I. Renal manifestations in inflammatory bowel disease: a systematic review. J Gastroenterol 2022. [PMID: 35834005 DOI: 10.1007/s00535-022-01903-6] [Reference Citation Analysis]
2 Singh U, Singh B, Bellini MI. Immunosuppressive regimens and outcomes of inflammatory bowel disease patients requiring kidney transplantation. World J Transplant 2022; 12(2): 21-23 [DOI: 10.5500/wjt.v12.i2.21] [Reference Citation Analysis]
3 Zhao L, Ren G, Fan R, Feng X, Liu Z, Cheng Z, Zhang T. Spectrum and prognosis of renal histopathological lesions in patients with inflammatory bowel disease: a cross-sectional study from a single center in China. Clin Exp Med 2021. [PMID: 34698949 DOI: 10.1007/s10238-021-00766-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Barahona-Correa JE, Morales SD, Andrade-Pérez R, Hani A. Renal Amyloidosis and Crohn Disease. Ochsner J 2021;21:291-5. [PMID: 34566512 DOI: 10.31486/toj.20.0129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Navrátil V, Cveková S, Slodička P, Aiglová K, Pipek B, Falt P. Extraintestinal complications of inflammatory bowel diseases. Vnitr Lek 2021;67:92-96. [DOI: 10.36290/vnl.2021.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Marotto D, Atzeni F, Ardizzone S, Monteleone G, Giorgi V, Sarzi-Puttini P. Extra-intestinal manifestations of inflammatory bowel diseases. Pharmacol Res 2020;161:105206. [PMID: 32998068 DOI: 10.1016/j.phrs.2020.105206] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
7 Hansrivijit P, Puthenpura MM, Thongprayoon C, Brar HS, Bathini T, Kovvuru K, Kanduri SR, Wijarnpreecha K, Cheungpasitporn W. Incidence and Impacts of Inflammatory Bowel Diseases among Kidney Transplant Recipients: A Meta-Analysis. Medical Sciences 2020;8:39. [DOI: 10.3390/medsci8030039] [Reference Citation Analysis]
8 Blesl A, Rainer F, Pollheimer M, Kump P, Durchschein F, Wenzl H, Eller K, Krisper P, Petritsch W, Högenauer C. Successful Pregnancies After Regression of AA Amyloidosis by Anti-inflammatory Therapy in Chronic Active Crohn's Disease. Dig Dis Sci 2020;65:2730-4. [PMID: 31865490 DOI: 10.1007/s10620-019-05988-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Lew SQ, Radhakrishnan J. Chronic Kidney Disease and Gastrointestinal Disorders. Chronic Renal Disease 2020. [DOI: 10.1016/b978-0-12-815876-0.00033-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Mutalib M. Renal involvement in paediatric inflammatory bowel disease. Pediatr Nephrol 2021;36:279-85. [PMID: 31820145 DOI: 10.1007/s00467-019-04413-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Woźniak M, Barańska M, Małecka-Panas E, Talar-Wojnarowska R. The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease. Prz Gastroenterol 2019;14:39-47. [PMID: 30944676 DOI: 10.5114/pg.2019.83424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Park S, Chun J, Han KD, Soh H, Choi K, Kim JH, Lee J, Lee C, Im JP, Kim JS. Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study. World J Gastroenterol 2018; 24(42): 4798-4808 [PMID: 30479466 DOI: 10.3748/wjg.v24.i42.4798] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
13 Ambruzs JM, Larsen CP. Renal Manifestations of Inflammatory Bowel Disease. Rheum Dis Clin North Am 2018;44:699-714. [PMID: 30274631 DOI: 10.1016/j.rdc.2018.06.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
14 Tei M, Uchida K, Chambers JK, Watanabe KI, Tamamoto T, Ohno K, Nakayama H. Variation of amino acid sequences of serum amyloid a (SAA) and immunohistochemical analysis of amyloid a (AA) in Japanese domestic cats. J Vet Med Sci 2018;80:164-72. [PMID: 29199213 DOI: 10.1292/jvms.17-0447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Sharma P, Aguilar R, Siddiqui OA, Nader MA. Secondary systemic amyloidosis in inflammatory bowel disease: a nationwide analysis. Ann Gastroenterol 2017;30:504-11. [PMID: 28845105 DOI: 10.20524/aog.2017.0168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
16 Saubermann LJ, Deneau M, Falcone RA, Murray KF, Ali S, Kohli R, Ekong UD, Valentino PL, Grossman AB, Rand EB, Jonas MM, Saeed SA, Kamath BM. Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees. J Pediatr Gastroenterol Nutr 2017;64:639-52. [PMID: 27984347 DOI: 10.1097/MPG.0000000000001492] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
17 Ricciuto A, Kamath BM. Liver Disease in Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2017. [DOI: 10.1007/978-3-319-49215-5_11] [Reference Citation Analysis]
18 Tosca Cuquerella J, Bosca-Watts MM, Anton Ausejo R, Tejedor Alonso S, Mora De Miguel F, Minguez Perez M. Amyloidosis in Inflammatory Bowel Disease: A Systematic Review of Epidemiology, Clinical Features, and Treatment. J Crohns Colitis 2016;10:1245-53. [PMID: 27056947 DOI: 10.1093/ecco-jcc/jjw080] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
19 Abbate R, Al-Daghri NM, Andreozzi P, Borregaard N, Can G, Caridi G, Carstensen-Kirberg M, Cioni G, Conte E, Cuomo R, Denis MA, Fakhfouri G, Fakhfouri G, Fiasse R, Glenthøj A, Goliasc G, Gremmel T, Herder C, Iemmolo M, Jing ZC, Krause R, Marrone O, Miazgowski B, Miazgowski T, Minchiotti L, Mousavizadeh K, Ndrepepa G, Niessner A, Ogayar Luque C, Onat A, Papassotiriou I, Ruiz Ortiz M, Sabico S, Schooling CM, Sakka SD, Sołtysiak P, Visseren FL, Wagner J, Wang XJ, Westerink J. Research update for articles published in EJCI in 2013. Eur J Clin Invest 2015;45:1005-16. [PMID: 26394055 DOI: 10.1111/eci.12512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Chachu KA, Osterman MT. How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBD. Inflamm Bowel Dis 2016;22:1262-74. [PMID: 26891261 DOI: 10.1097/MIB.0000000000000726] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
21 Schnitzler F, Friedrich M, Stallhofer J, Schönermarck U, Fischereder M, Habicht A, Karbalai N, Wolf C, Angelberger M, Olszak T, Beigel F, Tillack C, Göke B, Zachoval R, Denk G, Guba M, Rust C, Grüner N, Brand S. Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort. PLoS One 2015;10:e0135807. [PMID: 26288187 DOI: 10.1371/journal.pone.0135807] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
22 Doganavsargil B, Buberal GE, Toz H, Sarsik B, Pehlivanoglu B, Sezak M, Sen S. Digitally reinforced hematoxylin-eosin polarization technique in diagnosis of rectal amyloidosis. World J Gastroenterol 2015; 21(6): 1827-1837 [PMID: 25684948 DOI: 10.3748/wjg.v21.i6.1827] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
23 Ombrello AK, Aksentijevich I. AA Amyloidosis. Current Clinical Pathology 2015. [DOI: 10.1007/978-3-319-19294-9_3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Lew SQ, Radhakrishnan J. Chronic Kidney Disease and Gastrointestinal Disorders. Chronic Renal Disease 2015. [DOI: 10.1016/b978-0-12-411602-3.00025-1] [Reference Citation Analysis]
25 Yarur AJ, Czul F, Levy C. Hepatobiliary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2014;20:1655-67. [PMID: 24874461 DOI: 10.1097/MIB.0000000000000065] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
26 Gould M, Zarrin-Khameh N, Sellin J. Small bowel amyloidosis. Curr Gastroenterol Rep. 2013;15:350. [PMID: 24065604 DOI: 10.1007/s11894-013-0350-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
27 Cañas-Ventura A, Rodríguez E, Andreu M, Márquez L. Tocilizumab in amyloidosis-associated kidney disease secondary to inflammatory bowel diseases. Dig Dis Sci 2013;58:2736-7. [PMID: 23864193 DOI: 10.1007/s10620-013-2776-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
28 Kummen M, Schrumpf E, Boberg KM. Liver abnormalities in bowel diseases. Best Practice & Research Clinical Gastroenterology 2013;27:531-542. [DOI: 10.1016/j.bpg.2013.06.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]